Jessica Dill, PT, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 24711 Highway 5, Lonsdale, AR 72087 Phone: 501-922-9933 Fax: 501-922-9934 |
Alyssa Erin Bailey, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 24711 Highway 5, Lonsdale, AR 72087 Phone: 501-922-9933 |
Chelsea Hobson, PT, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 24711 Highway 5, Lonsdale, AR 72087 Phone: 501-922-9933 |
Valerie Ann Laisure, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 25255 Highway 5, Suitee N, Lonsdale, AR 72087 Phone: 501-922-9911 Fax: 501-922-9930 |
Jordan Physical Therapy Center Inc Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 25255 Highway 5 Ste N, Lonsdale, AR 72087 Phone: 501-922-9911 Fax: 501-922-9930 |
Dr. Cardin Vo, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 24711 Highway 5, Lonsdale, AR 72087 Phone: 501-922-9933 |
Dr. Krista Janai Koder, DPT, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 24711 Highway 5, Lonsdale, AR 72087 Phone: 501-922-9933 |
Stephanie Joy Bird, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 24711 Ar-5, Lonsdale, AR 72087 Phone: 501-922-9933 |
News Archive
Researchers at Fox Chase Cancer Center have demonstrated that a protein called NEDD9 may be required for some of the most aggressive forms of breast cancer to grow. Their findings, based on the study of a mouse model of breast cancer, are presented in a recent issue of Cancer Research, available on-line now.
A new USC study published in the journal Pediatrics finds a heightened risk of death from medical causes for infants with histories of reported maltreatment, suggesting a need for ongoing care coordination between the child protection system and pediatric health providers.
People who live in urban areas where particulate air pollution is high tend to have higher blood pressure than those who live in less polluted areas, according to researchers from the University of Dusiburg-Essen in Germany.
Synta Pharmaceuticals Corp. announced that clinical results for two Phase 1 trials of STA-9090 in solid tumors, as well as 12 month updated survival results from the SYMMETRY trial of elesclomol in metastatic melanoma, were presented at the 2010 Annual Meeting of the American Society of Clinical Oncology (ASCO).
The new projections give Medicare an additional four years of solvency compared to last year's report by the trustees for Medicare and Social Security.
› Verified 4 days ago